A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids

20223 citationsJournal Articlegold Open Access

Authors

Agnieszka Ewa Sieradzka · Eclexys (Switzerland)

Bruno Naccini · Ospedale Regionale di Mendrisio

Massimiliano Fontana · Ospedale Regionale di Mendrisio

Abstract

Antisynthetase syndrome associated with interstitial lung disease (ILD) and myopathy can be successfully treated without corticosteroids.A combination of several immunosuppressive agents can be a therapeutic alternative in case of refractory ILD.

Topics & Keywords

Inflammatory Myopathies and Dermatomyositis Muscle and Compartmental Disorders Heterotopic Ossification and Related Conditions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Journal of Case Reports in Internal Medicine

Volume 9, Issue 7, pp. 003324-003324

DOI: 10.12890/2022_003324

Field-Weighted Citation Impact: 0.47